PRIMARY PERITONEAL CANCER
Clinical trials for PRIMARY PERITONEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new PRIMARY PERITONEAL CANCER trials appear
Sign up with your email to follow new studies for PRIMARY PERITONEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Ovarian cancer drug study halted before it even started
Disease control TerminatedThis study was designed to test an experimental drug called BAT8006 in people with ovarian cancer that stopped responding to platinum-based chemotherapy. The goal was to find the safest dose and see if the drug could shrink tumors. However, the study was withdrawn before any part…
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated May 26, 2026 03:09 UTC
-
New gene therapy shows promise in fight against ovarian cancer
Disease control OngoingThis study tests a new treatment called IMNN-001, a gene therapy that boosts the immune system, given together with standard chemotherapy for people newly diagnosed with advanced ovarian, fallopian tube, or primary peritoneal cancer. The goal is to see if the combination helps ke…
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Imunon • Aim: Disease control
Last updated May 26, 2026 02:48 UTC
-
New hope for hard-to-treat ovarian cancer? early trial tests triple-drug attack.
Disease control OngoingThis early-phase study tested whether adding zoledronic acid to a standard chemotherapy combination could help women with ovarian cancer that no longer responds to platinum-based drugs. The trial enrolled 14 women and measured changes in immune cells within tumors. The goal was t…
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New hope for ovarian cancer: targeted drug combo shows promise in mid-stage trial
Disease control OngoingThis study tests a two-step treatment for women whose ovarian, peritoneal, or fallopian tube cancer has returned after initial chemotherapy. First, participants receive a combination of carboplatin (a standard chemo) and mirvetuximab soravtansine (a targeted drug that attacks can…
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Can avastin stop hidden ovarian cancer after second-look surgery?
Disease control OngoingThis study tests whether the drug bevacizumab (Avastin) can help control ovarian, fallopian tube, or primary peritoneal cancer that was still found during a second-look surgery. About 35 adults with advanced-stage cancer who already had standard chemotherapy and surgery will rece…
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 18, 2026 12:07 UTC